Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
Key Highlights
- ➤Thomas J. Appio appointed interim Bausch + Lomb CEO, effective immediately
- ➤Brent Saunders departs Bausch + Lomb after serving as CEO since 2023
- ➤Bausch + Lomb and Bausch Health expect to raise full-year 2026 adjusted EBITDA guidance
- ➤Third-quarter performance and stronger remainder of 2026 underpin anticipated guidance increase
- ➤Bausch Health delivered 13 consecutive quarters of revenue and adjusted EBITDA growth excluding Bausch + Lomb
Expert Statements
Thomas J. Appio, Interim CEO of Bausch + Lomb and CEO of Bausch Health
“The opportunity to lead Bausch + Lomb is both a privilege and a responsibility that I embrace with great enthusiasm”
Thomas J. Appio, Interim CEO of Bausch + Lomb and CEO of Bausch Health
“Our company is built on the strength of our people, the quality of our portfolio and a relentless commitment to serving customers and patients around the world. With a strong foundation, we are well positioned to build on our momentum and deliver sustainable growth.”
Brent Saunders, Former CEO of Bausch + Lomb
“When I returned to Bausch + Lomb, I believed this company had tremendous potential”
Brent Saunders, Former CEO of Bausch + Lomb
“Today, it is stronger, more focused and better positioned for the future, with a clearer strategy, a more robust pipeline and significant opportunities ahead. The progress we've made reflects the talent, passion and commitment of colleagues across the organization, and I'm proud of everything we've accomplished together.”
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), today announced that Bausch + Lomb Board of Directors Chairman Thomas J. Appio has been appointed interim chief executive officer, effective immediately. Appio will continue to serve as CEO of Bausch Health while assuming leadership of Bausch + Lomb.
Get started
Create a free account to read the full story.